News Regeneron's Inmazeb named Galien's Best Biotech Product The Galien Foundation, which acknowledges “extraordinary scientific innovations that improve the human condition”, has awarded its
News Lilly grabs first-ever FDA nod for a sleep apnoea drug Lilly's Zepbound has become the first drug approved by the FDA for obese patients with obstructive sleep apnoea, which affects millions in the US.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
